This inventor holds 6 USPTO granted patents and 4 published patent applications and 3 EPO patents. Top assignee: Icahn School of Medicine at Mount Sinai. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: The Innovations of Andrew F. Stewart
Introduction
Andrew F. Stewart is a prominent inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the development of kinase inhibitor compounds. With a total of five patents to his name, Stewart's work has the potential to impact various medical conditions.
Latest Patents
Among his latest patents are innovative compounds designed to inhibit the activity of DYRK1A in cells. These compounds are described in detail, including their structure and various forms such as stereoisomers and pharmaceutically acceptable salts. The patents also outline methods for increasing cell proliferation in pancreatic beta cells, treating conditions associated with insufficient insulin secretion, and addressing neurological disorders.
Career Highlights
Andrew F. Stewart is affiliated with the Icahn School of Medicine at Mount Sinai, where he continues to advance his research. His work is characterized by a commitment to developing therapeutic solutions that address critical health issues.
Collaborations
Stewart collaborates with notable colleagues, including Peng Wang and Kunal Kumar, enhancing the scope and impact of his research endeavors.
Conclusion
Andrew F. Stewart's innovative work in kinase inhibitor compounds exemplifies the intersection of research and practical application in medicine. His contributions are paving the way for new treatments and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile